Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

HealthDay News — A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S. population, according to a study presented at the American ...

A DNA methylation test is one of several noninvasive biomarkers test under investigation for the early diagnosis of bladder cancer.

Lung ultrasound (LUS) may be an effective screening tool for interstitial lung disease in patients with asymptomatic rheumatoid arthritis.

A preliminary modeling study suggests that four variables accessible at discharge could predict the risk for 90-day ...

A urinary DNA methylation test demonstrated a high sensitivity for detecting high-grade or invasive bladder cancer, ...

The following is a summary of “Oakland score to identify low-risk patients with lower gastrointestinal bleeding performs well among emergency department patients,” published in the February 2025 issue ...

Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...

Discover the revolutionary blood test offering a less invasive alternative to colonoscopies for colorectal cancer detection.

The sensitivity for CRC was 79.2%. The specificity for advanced colorectal neoplasia was 91.5%. The negative predictive value for advanced colorectal neoplasia was 90.8%, and the positive ...

We compared the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and Dice similarity ... The AI alone showed a positive predictive value (PPV) of 93.1% and a ...

Vessel-level analysis highlighted a significant improvement in specificity (98.0% vs 93.0%; P < 0.001), positive predictive value (83.3% vs 63.0%; P = 0.002), and diagnostic accuracy (97.2% vs 92.8%; ...